Navigation Links
New drug combination could prevent head and neck cancer in high-risk patients
Date:2/19/2013

nitiation. Biopsies at baseline and follow-up were available for seven patients.

Pathologic examination of the biopsies indicated that three of the seven patients had a complete pathologic response; that is, there was no longer evidence of the precancerous lesions in the follow-up biopsy sample. Among the other patients, two had a partial pathologic response and two had progressive disease.

"Finding that this drug combination caused some advanced premalignant lesions to completely disappear was great news," said Shin. "Advanced premalignant lesions rarely regress, so our data are proof-of-principle that a combination chemopreventive strategy with molecularly targeted agents is possible."

Several patients dropped out of the trial because of severe adverse side effects, according to Shin. "Prevention is not achieved through short-term treatment," he said. "So, we need to investigate the safety and toxicity of this combination further before planning a large-scale trial. We are also looking to combination therapies using less toxic or nontoxic agents, such as natural compounds."


'/>"/>

Contact: Jeremy Moore
jeremy.moore@aacr.org
215-446-7109
American Association for Cancer Research
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mayo Clinic: 2-drug combination may slow deadly thyroid cancer
2. People with HIV hospitalized less often since combination antiretroviral drug therapy introduced
3. Combination of imaging exams improves Alzheimers diagnosis
4. Drug combination acts against aggressive chronic lymphocytic leukemia
5. Scientists test 5,000 combinations of 100 existing cancer drugs to find more effective treatments
6. Combination treatment may improve survival of breast cancer patients with brain metastases
7. Drug combination against NRAS-mutant melanoma discovered
8. Combination peptide therapies might offer more effective, less toxic cancer treatment
9. DNDi and Cipla to develop 4-in-1 pediatric antiretroviral drug combination
10. BUSM in vitro study identifies potential combination therapy for breast cancer
11. Moffitt Cancer Center researchers test drug combinations to prevent graft vs. host disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... September 01, 2014 Registration is now open ... 5K and 1-Mile Race to be held on Sunday, September ... Court Yard at Harmon Meadow in Secaucus, New Jersey. All ... a national nonprofit dedicated to restoring a sense of self, ... members and our military families. , General registration is $30 ...
(Date:9/1/2014)... 01, 2014 Ontraport , one ... that was developed to automate the small intricacies of ... of Shane Michaels, prompting an investigative review. , ... duty of managing all of the small details involved ... overwhelming,” reports Michaels. “That’s why Ontraport has become so ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 The Outlier ... with extended exclusive interview content from one of the ... Ingredients of Outliers: Women Game Changers . The title ... Outliers: Woman Game Changer Jenny McClendon . McClendon is ... and was formerly the star of WeTV show, Raising ...
(Date:9/1/2014)... (PRWEB) September 01, 2014 Pastor Thompson is ... Specialist at Eagle Village. He is a licensed minister through ... over the past twenty years in New Mexico, Colorado and ... years of marriage this year. He also has two ... a B.S. in Pastoral Ministry from Nazarene Bible College, in ...
(Date:9/1/2014)... September 01, 2014 Beginning Tuesday, September ... 3,000 medical professionals and 10,000 consumers for the annual ... 5-day gathering of the nation’s top medical professionals who ... or conditions. The week-long event contains more than 120 ... instruction available in the pain management field. , MarijuanaDoctors.com ...
Breaking Medicine News(10 mins):Health News:Hope For The Warriors New Jersey Run to Honor Wounded and Families of the Fallen 2Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 2Health News:Upcoming Outlier Series eBook about Jenny McClendon, PA-C, Former Start of Raising Sextuplets 3Health News:Medical Marijuana Doctor Company Set to Present at Las Vegas Pain Week 2
... , , Tanya Zuckerbrot, ... food satisfying to both the belly and brain , ... research suggests that there are important psychological factors to consider when ... with natural fiber and protein may be the most physiologically satisfying(1-3), ...
... ... directory at the fingertips of the Florida legal community. With a few quick mouse ... FindFloridaLawyer.com. , ... -- Finding appropriate legal representation can be challenging, especially with so many choices available. ...
... , "AF Stat(TM) Call to Action for ... as Key Barriers to Improved Outcomes , , ... today released the AF Stat(TM) Call to Action for ... the burden of atrial fibrillation (AFib) in the United States. ...
... , , , , ... energy, superfoods and exotic ingredients grows, rainforest-grown yerba mate ... sensation to hit the market. , , ... Guayaki , a pioneer and leader in the yerba mate ...
... , , FARMINGTON HILLS, ... acquired the stock and assets of GTL, Inc. dba as ... integrate its product and service offerings into CST to provide ... the independence and quality of life for older adults, the ...
... transplantation (LDLT) has been used to alleviate the shortage of ... (SLV) of the living donor and recipient is crucial. Scholars ... but which formula was the most accurate for Chinese adults ... research article to be published on August 28, 2009 in ...
Cached Medicine News:Health News:Study: Psychology of Food Choices, What It Takes to Feel Truly Satisfied 2Health News:Study: Psychology of Food Choices, What It Takes to Feel Truly Satisfied 3Health News:Study: Psychology of Food Choices, What It Takes to Feel Truly Satisfied 4Health News:FindFloridaLawyer.com Announces the Grand Opening of Its Online Attorney Search and Legal Resource Site 2Health News:Health Leaders Issue Recommendations to Improve Management of a Common, Costly and Misunderstood Cardiovascular Disease: Atrial Fibrillation 2Health News:Health Leaders Issue Recommendations to Improve Management of a Common, Costly and Misunderstood Cardiovascular Disease: Atrial Fibrillation 3Health News:Health Leaders Issue Recommendations to Improve Management of a Common, Costly and Misunderstood Cardiovascular Disease: Atrial Fibrillation 4Health News:Health Leaders Issue Recommendations to Improve Management of a Common, Costly and Misunderstood Cardiovascular Disease: Atrial Fibrillation 5Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 2Health News:Guayaki Delivers Powerful Rainforest Experience with Newest Yerba Mate Beverage Innovations 3Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 2Health News:Critical Signal Technologies Acquires Link to Life to Grow Depth and Expertise in TeleHealth, Personal Emergency Response and Medical Monitoring Systems 3
(Date:8/29/2014)... Medina Medical announced today that Mr. Engelson ... Board of Directors on August 18, 2014. Mr. Engelson ... experience, including over a decade of direct experience in ... Partner of the medical device incubator The Foundry, after ... start-ups. Mr. Engelson previously served as the Chief Financial ...
(Date:8/29/2014)... Research and Markets has announced the addition ... Pipeline Insight 2014" report to their offering. ... eradicate the prevalence of cancer have achieved limited success ... specificity, safety and large number of side effects, which ... It has been discovered that peptides can be used ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets ... and Development Trend Forecast of Pharmaceutical Equipment Market in ... Research and Development Trend Forecast of Pharmaceutical Equipment ... analyzes China,s pharmaceutical equipment industry ... demand, competition landscape, and business performance of domestic major ...
Breaking Medicine Technology:Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2Research and Development Trend Forecast of Pharmaceutical Equipment Market in China, 2014-2018 2
... 3 ,GlaxoSmithKline (NYSE: GSK ; LSE) today ... has granted Priority Review for PROMACTA(R),(eltrombopag) for the ... (ITP). PROMACTA is an investigational,once-daily oral treatment that ... to generate platelets, which are critical in minimizing ...
... Shows Statistically Significant Pain Relief with the 2.5 ... and 5 mg Doses ... Alexza,Pharmaceuticals, Inc. (Nasdaq: ALXA ) announced today positive top-line,results ... (Staccato(R),loxapine) in patients with migraine headache. Migraine is a debilitating,yet ...
Cached Medicine Technology:FDA Grants Priority Review for PROMACTA(R) (eltrombopag) 2FDA Grants Priority Review for PROMACTA(R) (eltrombopag) 3FDA Grants Priority Review for PROMACTA(R) (eltrombopag) 4Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 2Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 3Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 4Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 5Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 6Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 7Alexza's AZ-104 (Staccato(R) Loxapine) Phase 2a Trial Meets Primary Endpoint of 2-Hour Pain Relief in Patients with Migraine Headache 8
Porous foundation 480 series....
Cemented foundation 460 series....
Porous foundation 440 series....
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
Medicine Products: